Skip to main content

Table 2 Comparison of adverse maternal complications

From: Proteinuria may be an indicator of adverse pregnancy outcomes in patients with preeclampsia: a retrospective study

  Non-PE PE p value Subgroupsb p value
A B C
Numbera 54 275   53 64 53  
Mode of delivery
 Spontaneously (%) 38 (70.4) 24 (8.7) <  0.001 6 (11.3) 1 (1.7) 1 (5.7) 0.038
 Caesarean section (%) 14 (25.9) 232 (84.4)   46 (86.8) 59 (92.2) 42 (79.2)  
 Adverse maternal outcomes (%) 2 (3.7) 92 (33.5) <  0.001 11 (21) 21 (32.8) 26 (49.1) 0.009
 Retinal disease (%) 0 19 (6.9) 0.047 1 (1.9) 2 (3.1) 3 (5.7) 0.561
 Hypoproteinemia (%) 1 (1.9) 44 (16) 0.006 3 (5.7) 8 (12.5) 19 (35.8) < 0.001
 Organ dysfunctionc (%) 0 20 (7.3) 0.041 3 (5.7) 0 7 (13.2) 0.010
 Placental abruption (%) 0 10 (3.6) 0.155 1 (1.9) 3 (4.7) 1 (1.9) 0.578
 Oligohydramnios (%) 0 29 (10.6) 0.012 6 (11.3) 8 (12.5) 3(11.3) 0.437
 Effusiond (%) 0 2 (0.7) 0.53 0 0 1 (1.9) 0.329
 Eclampsia (%) 0 1 (0.4) 0.657 0 0 0
 Postpartum hemorrhage (%) 2 (3.7) 3 (1) 0.151 0 1 (1.7) 0 0.435
 DIC (%) 0 2 (0.7) 0.53 0 0 0
 Hemorrhagic anemia (%) 1 (1.9) 6 (2.2) 0.878 0 0 1 (1.9) 0.329
 Maternal death (%) 0 1 (0.4) 0.657 0 0 0
  1. Numbera: The number of multiple adverse pregnancy outcomes was counted according to the types of adverse pregnancy outcomes
  2. Subgroupsb: A: 24-h urinary protein < 0.3 g; B:24-h urinary protein 0.3 ~ 2 g; C:24-h urinary protein 2 g
  3. Organ dysfunctionc: renal dysfunction, hepatic dysfunction or cardiac insufficiency
  4. Effusiond: including pleural or peritoneal effusion or pericardial effusion